Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-02-03 Valproic acid
| Valproic Acid Depakote® |
|
Formulary
|
Contrindiciated in women of childbearing potential unless part of the Pregnancy Prevention Programme. See MHRA guidance |
 Guidance Document on Valproate Use in Women and Girls of Childbearing Years (March 2019) Valproate form: Annual Risk Acknowledgement form (March 2019) MHRA: Valproate use in women and girls (August 2018) NICE CG38: Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care Women of childbearing potential: Educational Risk Minimisation Materials |
|
Use in men and women of non-child bearing potential
Use in women and girls of childbearing potential (all indications). ESCA link belowLinks
- Administration of depot antipsychotic injections during COVID-19 in stable adult patients
- ESCA: Black Country - Lithium (GP Monitoring)
- ESCA: Black Country - Lithium (GP Monitoring)
- ESCA: Black Country - Lithium (Hospital Monitoring)
- ESCA: Black Country - Lithium (Hospital Monitoring)
- ESCA: Lithium
- ESCA: Lithium
- Guidance Document on Valproate Use in Women and Girls of Childbearing Years (March 2019)
- MHRA: Valproate use in women and girls (August 2018)
- NHS England: (Schedule 3 Controlled Drugs) Patient Leaflet; Are you taking gabapentin or pregabalin? (Lyrica, Alzain, Neurontin)
- NICE CG103: Delirium
- NICE CG178: Psychosis and schizophrenia in adults
- NICE CG185: Bipolar disorder: assessment and management
- NICE CG38: Bipolar disorder
- NICE CG38: Bipolar disorder: The management of bipolar disorder in adults, children and adolescents, in primary and secondary care
- UKMI Q&A: Which drugs can cause Neuroleptic Malignant Syndrome?
- Valproate form: Annual Risk Acknowledgement form (March 2019)
- Women of childbearing potential: Educational Risk Minimisation Materials